Practice parameter for the assessment and treatment of children and adolescents with schizophrenia

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 40, Issue 7 SUPPL., 2001, Pages 4S-23S

  McClellan, J ^a,a   Werry, J ^a   Bernet, W ^a   Arnold, V ^a   Beitchman, J ^a   Benson, R S ^a   Bukstein, O ^a   Kinlan, J ^a   Rue, D ^a   Shaw, J ^a   Kroeger, K ^a  

^a American Academy of Child and Adolescent Psychiatry   (United States)

Author keywords

Adolescents; Children; Psychosis; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE;

ADOLESCENT DISEASE; AFFECTIVE NEUROSIS; AGRANULOCYTOSIS; ARTICLE; BEHAVIOR DISORDER; CHILD PSYCHIATRY; CLINICAL RESEARCH; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; HEALTH PROGRAM; HUMAN; MORBIDITY; ONSET AGE; ORGANIC BRAIN SYNDROME; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOTHERAPY; SCHIZOPHRENIA; SEIZURE; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 17944403195     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200107001-00002     Document Type: Article

References (125)

1. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development
2. Childhood-onset schizophrenia: Biological markers in relation to clinical characteristics
3. Childhood-onset schizophrenia: The severity of premorbid course
4. Subclinical hallucinations and delusions in nonpsychotic adolescents
5. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder
6. Practice parameters for psychiatric assessment of children and adolescents
7. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders
8. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder
9. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders
10. Practice guideline for the treatment of patients with schizophrenia
11. Schizophrenia in hospitalized adolescents: Clinical diagnosis, DSM-III-R, DSM-IV, and ICD-10 criteria
12. Risperidone in adolescents with schizophrenia: An open pilot study
13. Children with schizophrenia spectrum and depressive disorders: A comparative study of premorbid adjustment, onset pattern and severity of impairment
14. Parental communication deviance in childhood onset schizophrenia spectrum and depressive disorders
15. Childhood onset schizophrenia: A follow-up study
16. Cognitive/neuropsychological studies of children with a schizophrenic disorder
17. Disorders of language, speech, and communication
18. Speech and language disorders in children and adolescents with schizophrenia
19. Childhood schizophrenia: A review and comparison with adult-onset schizophrenia
20. A review of ECT for children and adolescents
21. Positive and negative symptoms in psychotic and other psychiatrically disturbed children
22. Antipsychotics in children and adolescents
23. Childhood schizophrenia, present but not accounted for
24. Communication deficits in children with schizophrenia spectrum disorders
25. The Kiddie Formal Thought Disorder Scale: Clinical assessment, reliability, and validity
26. Conversational repair in schizophrenic and normal children
27. Child and adolescent mania: Diagnostic considerations
28. Hallucinations in children: A follow-up study
29. Risperidone side effects
30. Course and prognosis in childhood schizophrenia
31. Schizoaffective psychosis in childhood: A follow-up study
32. The long-term course of childhood-onset schizophrenia: A 42-year followup
33. Substances of abuse
34. Antipsychotics (neuroleptics)
35. Psychiatric diagnoses of maltreated children: Preliminary findings
36. Risperidone and tardive dyskinesia
37. Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect
38. Psychoses of childhood
39. Pubertal development and onset of psychosis in childhood onset schizophrenia
40. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia
41. Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs
42. Cognitive dysfunction in schizophrenia: A new set of tools for the assessment of cognition and drug effects
43. Hallucinations in children with conduct and emotional disorders, I: The clinical phenomena
44. Hallucinations in children with conduct and emotional disorders, II: The follow-up study
45. Characteristics of the psychoses of late onset in children and adolescents: A comparative study of hallucinating children
46. Intellectual impairment in adolescent psychosis: A controlled psychometric study
47. Childhood-onset schizophrenia: An NIMH study in progress
48. Risperidone in the treatment of children and adolescents with schizophrenia: A retrospective study
49. A comparison of schizophrenic and autistic children
50. Schizophrenic disorder in childhood: Its relationship to DSM-III criteria
51. Schizophrenia with childhood onset: A phenomenological study of 38 cases
52. Epidemiology of early-onset schizophrenia
53. Quetiapine in adolescent psychosis
54. Psychosocial skills training for schizophrenia: Lessons from the laboratory
55. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, I: One-year effects of a controlled study on relapse and expressed emotion
56. Child and adolescent (juvenile onset) schizophrenia: A case control study of premorbid developmental impairments
57. Clinical phenomenology of child and adolescent dissociative disorders
58. Quantitative morphology of the cerebellum and fourth ventricle in childhood-onset schizophrenia
59. Research update: Childhood-onset schizophrenia: Implications of clinical and neurobiological research
60. Age of onset in bipolar affective disorder and misdiagnosis of schizophrenia
61. The contribution of neuropathologic studies to the understanding of autism
62. Cognitive impairment in adolescents with schizophrenia
63. Influence of race on diagnosis in adolescent psychiatric inpatients
64. Studies in the childhood psychoses
65. Including children and adolescents with schizophrenia in medication-free research
66. Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison
67. Case study: Risperidone-induced hepatotoxicity in pediatric patients
68. "Multidimensionally impaired disorder": Is it a variant of very early-onset schizophrenia?
69. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials
70. A prospective follow-up study of so-called borderline children
71. Sex differences in age at onset of schizophrenia
72. Risperidone in children with schizophrenia
73. Olanzapine in the treatment of early-onset schizophrenia in children and adolescents
74. Risperidone treatment of children and adolescents: Increased risk of extrapyramidal side-effects
75. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence, II: Positive/negative distinction and childhood predictors of adult outcome
76. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence, I: Nosology, sex and age of onset
77. Early onset schizophrenia
78. Neurocognitive pathways in the development of schizophrenia
79. Early onset psychotic disorders: Diagnostic stability and clinical characteristics
80. Early onset psychotic disorders: Course and outcome over a two year period
81. A follow-up study of early onset psychosis: Comparison between outcome diagnoses of schizophrenia, mood disorders and personality disorders
82. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine in adolescents with selected psychotic disorders
83. Adolescent versus adult onset of mania
84. Looking for childhood-onset schizophrenia: The first 71 cases screened
85. Recent advances in the pharmacotherapy of schizophrenia
86. Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance
87. Abnormal involuntary movement scale
88. Childhood-onset schizophrenia: Rare but worth studying
89. A controlled evaluation of Loxitane in seventy-five adolescent schizophrenia patients
90. Cognitive improvement in schizophrenia with novel antipsychotic medications
91. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol: The Canadian Collaborative Group for research in schizophrenia
92. Case study: Risperidone in children and adolescents with schizophrenia
93. Childhood-onset schizophrenia: Progressive ventricular change during adolescence
94. Progressive cortical change during adolescence in childhood-onset schizophrenia: A longitudinal magnetic resonance imaging study
95. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents
96. The concept of positive and negative schizophrenia in child and adolescent psychiatry
97. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
98. The Psychosis Project: Outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescents
99. The phenomenology of schizophrenia occurring in childhood
100. Childhood schizophrenia reconsidered
101. Neuroleptic malignant syndrome in children and adolescents
102. Risperidone effects in treatment-resistant adolescents: Preliminary case reports
103. Haloperidol in schizophrenic children: Early findings from a study in progress
104. Quetiapine for refractory schizophrenia
105. Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia
106. Schizophrenia with childhood and adolescent onset: A nationwide register-based study
107. Use of atypical neuroleptics in child and adolescent psychiatry
108. Conceptualizing "borderline syndrome of childhood" and "childhood schizophrenia" as a developmental disorder
109. Velocardiofacial syndrome in childhood-onset schizophrenia
110. Comorbid association of autism and schizophrenia
111. Phenomenology and classification of the childhood psychoses
112. Symptom development in childhood onset schizophrenia
113. Implications of normal brain development for the pathogenesis of schizophrenia
114. Psychoses
115. Child and adolescent (early onset) schizophrenia: A review in light of DSM-III-R
116. Predicting outcome in child and adolescent (early onset) schizophrenia and bipolar disorder
117. Early-onset schizophrenia, bipolar and schizoaffective disorders: A clinical follow-up study
118. Schizophrenia and allied disorders
119. Comparison of adult manifestations of schizophrenia with onset before and after 15 years of age
120. Autonomic nervous system markers of psychopathology in childhood-onset schizophrenia